Photo-thermal stability of praziquantel

Saudi Pharmaceutical Journal

Volumn 12, Issue 4, 2004, Pages 157-162

  Suleiman, Moutasim I ^a   Karim, Elfatih I A ^a   Ibrahim, Kamal E E ^a   Ahme, Babiker M ^a   Saeed, Ahmed E M ^a   Hamid, Ahmed E M E ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b Amipharma Laboratories   (Sudan)

Author keywords

Kinetics; Photodecomposition; Praziquantel (PZQ); Stability; Thermal decomposition

Indexed keywords

BENZOIC ACID; CARBOXYMETHYLCELLULOSE; CITRATE POTASSIUM; EXCIPIENT; GLYCEROL; METHYL PARABEN; POLYSORBATE 80; PRAZIQUANTEL; PROPYL PARABEN; PROPYLENE GLYCOL; SACCHARIN SODIUM; SODIUM HYDROXIDE; WATER;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION KINETICS; DRUG DEGRADATION; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; PH; PHOTODEGRADATION; PROTON NUCLEAR MAGNETIC RESONANCE; SUDAN; SUNLIGHT; TEMPERATURE; THERMOSTABILITY; THIN LAYER CHROMATOGRAPHY;

EID: 11144297113     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bergquist NR (2000): Schistosomiasis from risk assessment to control. Trend Parasitol, 18 (7): 309-14.
2. Harder A. (2002): Chemotherapeutic approaches to schistosomiasis: curvent knowledge and outlook. Parasitol. Res. 88 (5): 395-7.
3. Seubert, J., Pohlke, R. and Loebich, F. (1977). Synthesis and properties of Praziquantel, a novel broad-spectrum anthelminite with excellent activity against schistosomes and cestodes. Experientia, 33: 1036.
4. Richard, D.; Pearson, M.D.: Richard, L.; Gureant, M.D.; Charlottesville Virginia (1983). Praziquantel: A major advance in anthelminite therapy. Annals of Internal Medicine, 99: 195-198.
5. Ismail MM., Farghaly AM, Dyab AK, Afify HA, El-shafei MA (2002): Resistance to PZQ, effect of drug pressure and stability test. J. Egypt. Soc. Parasitol. 32 (2): 589-600.
6. Becket G., Schp J., Tan MY (1999): Improvement of the invitro dissolution of Praziquantel by completion with alpha-beta and gamma cyclodextrins. Int. J. Pharm., 79 (1): 65-7.
7. El-Arini SK, Giron D, Leuenberger H (1999): Solubility properties of Praziquantel and its enantiomers. Pharm. Dev. Technol, 3 (4): 557-64.
8. Ridtitid W., Wongnawa M., Mahatthanatrakul W., Punyo J., Sunbhanich M. (2002): LC determination of praziquantel in human plasma. J. Pharm. Biomed Anal., 28(1): 181-6.
9. Mandour, M.E.; Hamid, E. Turabi; Mamoun, M.A. Hoemida; Taha El Sadig; Hassan M. Ali; James L. Bennet; William J. Leahey; and Dean W.O. Harron (1990): Pharmacokinetics of praziquantel in healthy volunteers and patients with Schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 84: 388-393.
10. Ahmed E.M. Saeed, Elfatih I.A. Karim, Babiker M. Ahmed, Kamal E.E. Ibrahim, Moutasim I. Suleiman, Suad M. Sulaiman (2003). Synthesis of some derivatives of the open lactam from Praziquantel and their in-vivo -in-vivo cyclization. Saudi Pharmaceutical Journal, 11 (4): 172-183.
11. Karim, E.I.A., Ibrahim, K.E. and Adam, M.E. (1991). Studies on the photo-decomposition of metronidazole. Int. J. Pharm., 76: 261-264.
12. Saleh, H. and Schnekenburger, J. (1992). Colorimetric method for the quantitative determination of the antibilharzial drug. Praziquantel and its application to pharmaceutical preparations. Analyst. 117: 87-92.
13. th Edition (2002): Published by the Directorate for the Quality of Medicines of the Council of Euorope (EDQM), Strasbourg. Page:712, 984, 1255, 1557, 1783, 1787, 1827, 1828, 1874, and 1902.